[PDF][PDF] The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways

T Kataoka, RC Budd, N Holler, M Thome, F Martinon… - Current biology, 2000 - cell.com
T Kataoka, RC Budd, N Holler, M Thome, F Martinon, M Irmler, K Burns, M Hahne…
Current biology, 2000cell.com
Abstract Background: Activation of Fas (CD95) by its ligand (FasL) rapidly induces cell death
through recruitment and activation of caspase-8 via the adaptor protein Fas-associated
death domain protein (FADD). However, Fas signals do not always result in apoptosis but
can also trigger a pathway that leads to proliferation. We investigated the level at which the
two conflicting Fas signals diverge and the protein (s) that are implicated in switching the
response. Results: Under conditions in which proliferation of CD3-activated human T …
Abstract
Background: Activation of Fas (CD95) by its ligand (FasL) rapidly induces cell death through recruitment and activation of caspase-8 via the adaptor protein Fas-associated death domain protein (FADD). However, Fas signals do not always result in apoptosis but can also trigger a pathway that leads to proliferation. We investigated the level at which the two conflicting Fas signals diverge and the protein(s) that are implicated in switching the response.
Results: Under conditions in which proliferation of CD3-activated human T lymphocytes is increased by recombinant FasL, there was activation of the transcription factors NF-κB and AP-1 and recruitment of the caspase-8 inhibitor and FADD-interacting protein FLIP (FLICE-like inhibitory protein). Fas-recruited FLIP interacts with TNF-receptor associated factors 1 and 2, as well as with the kinases RIP and Raf-1, resulting in the activation of the NF-κB and extracellular signal regulated kinase (Erk) signaling pathways. In T cells these two signal pathways are critical for interleukin-2 production. Increased expression of FLIP in T cells resulted in increased production of interleukin-2.
Conclusions: We provide evidence that FLIP is not simply an inhibitor of death-receptor-induced apoptosis but that it also mediates the activation of NF-κB and Erk by virtue of its capacity to recruit adaptor proteins involved in these signaling pathways.
cell.com